600713.SS
600713.SS
CNE000000KV1
NANJING PHARMACEUTICAL GP CO LT
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 54.963.277.450 53.696.173.896
2.4%
Cost of Revenue 51.580.940.619 50.323.077.943
2.5%
Gross Profit 3.382.336.831 3.373.095.953
0.3%
1.848.736.726 1.782.069.226
3.7%
Operating Income 1.533.600.104 1.591.026.727
3.6%
Pretax Income 1.157.627.934 1.003.395.389
15.4%
Net Income Common Stockholders 624.834.795 570.627.553
9.5%
-- --
--
-- --
--
ende